Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans
- PMID: 10409475
Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans
Abstract
Both atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are involved in sodium and water homoeostasis in healthy humans. The plasma concentrations of the natriuretic peptides can be used to differentiate between dyspnoea of cardiac and pulmonary origin, and the degree of elevation of the peptide levels in the plasma in heart failure is a measure of the severity of the disease. However, the patterns of secretion of ANP and BNP are not clear either in healthy humans or in patients. The purpose of the present study was to test the hypotheses that both ANP and BNP are secreted in pulses in healthy humans, and that this phenomenon can be revealed by determination of ANP and BNP in peripheral venous blood samples. In 12 healthy subjects, blood samples were drawn every 2 min through an intravenously inserted plastic needle over a period of 2 h. Plasma concentrations of ANP and BNP were determined by RIAs, and the results were analysed for pulsatile behaviour by Fourier transformation. Pulsatile secretion of ANP was seen in 10 out of 12 subjects [nu=0.028 min(-1) (median; range 0.013-0.047 min(-1)), i.e. a pulse of ANP with an interval of 36 min (range 21-77 min)]. Pulsatile secretion of BNP was seen in nine out of 12 patients [nu=0. 021 min(-1) (range 0.013-0.042 min(-1)), i.e. a pulse of BNP with an interval of 48 min (range 24-77 min)]. The main conclusion is that the secretion patterns of both ANP and BNP are pulsatile in most healthy humans. Consequently, it is important to study whether pulsatile secretion also occurs in heart failure in order to obtain the most informative predictive values both in the differential diagnosis of dyspnoea and in the evaluation of the severity of the disease.
Similar articles
-
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.Clin Sci (Lond). 2006 Apr;110(4):491-501. doi: 10.1042/CS20050336. Clin Sci (Lond). 2006. PMID: 16396628 Clinical Trial.
-
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.Clin Sci (Lond). 2003 Mar;104(3):303-12. doi: 10.1042/CS20020138. Clin Sci (Lond). 2003. PMID: 12605591
-
Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.Int J Cardiol. 2005 Oct 20;105(1):31-9. doi: 10.1016/j.ijcard.2004.10.046. Int J Cardiol. 2005. PMID: 16207542
-
Dysregulation of pulsatility in aging IV. Pulsatile signaling and cardiovascular aging: functions and regulation of natriuretic peptide signaling.Ageing Res Rev. 2008 Jul;7(3):151-63. doi: 10.1016/j.arr.2007.12.001. Epub 2008 Feb 19. Ageing Res Rev. 2008. PMID: 18243818 Review.
-
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.Pharmacol Ther. 2004 Jun;102(3):223-41. doi: 10.1016/j.pharmthera.2004.04.004. Pharmacol Ther. 2004. PMID: 15246247 Review.
Cited by
-
Caveats in the interpretation of natriuretic peptide levels.Clinics (Sao Paulo). 2011;66(8):1479-80. doi: 10.1590/s1807-59322011000800027. Clinics (Sao Paulo). 2011. PMID: 21915502 Free PMC article. No abstract available.
-
Loop analysis of blood pressure/volume homeostasis.PLoS Comput Biol. 2019 Sep 12;15(9):e1007346. doi: 10.1371/journal.pcbi.1007346. eCollection 2019 Sep. PLoS Comput Biol. 2019. PMID: 31513566 Free PMC article.
-
Potential association between frequent nonsynonymous variant of NPPA and cardioembolic stroke.DNA Cell Biol. 2012 Jun;31(6):993-1000. doi: 10.1089/dna.2011.1463. Epub 2012 Mar 8. DNA Cell Biol. 2012. PMID: 22400494 Free PMC article.
-
B-type natriuretic peptide and renal disease.Heart Fail Rev. 2003 Oct;8(4):355-8. doi: 10.1023/a:1026195332025. Heart Fail Rev. 2003. PMID: 14574057 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous